Health Insurance Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
GlaxoSmithKline
Therapeutic nicotine has helped 5 million smokers quit since launch 10 years ago, Glaxo says
August 13th, 2006
GlaxoSmithKline (GSK) Consumer Healthcare marked the 10th anniversary of when therapeutic nicotine (TN) products became available over-the-counter (OTC) at the 13th World Conference on Tobacco OR Health (WCTOH). International guidelines from the United States, United Kingdom and the World Health Organization (WHO) recommend TN as a first-line treatment for smoking addiction. Quitters using therapeutic nicotine can double their chances of success versus quitting without help. Therapeutic nicotine products such as Nicorette gum, NicoDerm CQ patch and Commit lozenge, are available in more than 35,000 retail outlets in the United States and under the NiQuitin brand name in...
Source: Health Insurance Law Weekly (2006-08-13)
|
